Serum interleukin−21 as a biomarker for determining COVID−19 vaccination status in patients with myasthenia gravis: A cross−sectional study

NeuroMarkers · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles